A new study has found that lorcaserin decreased risk for diabetes, induced diabetes remission and reduced risk of diabetes complications in obese and overweight patients.
A new study has found that lorcaserin decreased risk for diabetes, induced diabetes remission and reduced risk of diabetes complications in obese and overweight patients.